Mirapex LA tablets 1.5 mg, manufactured by Nippon Boehringer Ingelheim, contain Pramipexole hydrochloride hydrate. This long-acting formulation is used for the symptomatic treatment of Parkinson’s disease. Its YJ code is 1169012G2024, with a standard dosage of 1.5 mg per tablet.
Mirapex LA tablets 1.5 mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
More with the same ingredient
